Right time to take profit off the table in pharma ; defence a structural buy : Rajiv (...)
Rajiv Batra addresses global investors' concerns about India's growth and policy, emphasizing the need for double-digit earnings and nominal GDP growth to reignite foreign investor interest. He suggests profit-taking in pharma due to US generic concerns and underwhelming earnings. Batra remains (...)
Site référencé: The Economic Times
The Economic Times
Paytm shares up 17% so far in 2025. Should you ride the rally or wait for a dip ?
14/08/2025
Vishal Mega Mart shares surge 8% after Q1 profit jumps 37% YoY
14/08/2025
Muthoot Finance shares hit 10% upper circuit on posting 65% YoY growth in Q1 profit
14/08/2025
Jubilant Foodworks shares rally 5% after Q1 PAT grows 60% YoY, but brokerages trim targets. Here’s why
14/08/2025
